Senhwa Biosciences Statistics
Total Valuation
TPEX:6492 has a market cap or net worth of TWD 3.47 billion. The enterprise value is 2.46 billion.
Market Cap | 3.47B |
Enterprise Value | 2.46B |
Important Dates
The last earnings date was Thursday, March 13, 2025.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6492 has 89.19 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 89.19M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 2.04% |
Owned by Institutions (%) | 0.17% |
Float | 68.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 3.38 |
P/TBV Ratio | 3.38 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.38 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -8.32 |
Financial Position
The company has a current ratio of 33.29, with a Debt / Equity ratio of 0.01.
Current Ratio | 33.29 |
Quick Ratio | 33.01 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.05 |
Interest Coverage | -461.83 |
Financial Efficiency
Return on equity (ROE) is -25.06% and return on invested capital (ROIC) is -16.16%.
Return on Equity (ROE) | -25.06% |
Return on Assets (ROA) | -15.76% |
Return on Invested Capital (ROIC) | -16.16% |
Return on Capital Employed (ROCE) | -29.59% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.27% in the last 52 weeks. The beta is 1.04, so TPEX:6492's price volatility has been similar to the market average.
Beta (5Y) | 1.04 |
52-Week Price Change | -12.27% |
50-Day Moving Average | 43.14 |
200-Day Moving Average | 46.77 |
Relative Strength Index (RSI) | 28.00 |
Average Volume (20 Days) | 162,615 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6492 had revenue of TWD 1.00 million and -293.75 million in losses. Loss per share was -3.29.
Revenue | 1.00M |
Gross Profit | 477,000 |
Operating Income | -306.19M |
Pretax Income | -292.46M |
Net Income | -293.75M |
EBITDA | -303.94M |
EBIT | -306.19M |
Loss Per Share | -3.29 |
Balance Sheet
The company has 1.03 billion in cash and 15.00 million in debt, giving a net cash position of 1.01 billion or 11.34 per share.
Cash & Cash Equivalents | 1.03B |
Total Debt | 15.00M |
Net Cash | 1.01B |
Net Cash Per Share | 11.34 |
Equity (Book Value) | 1.03B |
Book Value Per Share | 11.52 |
Working Capital | 1.00B |
Cash Flow
In the last 12 months, operating cash flow was -294.22 million and capital expenditures -1.95 million, giving a free cash flow of -296.17 million.
Operating Cash Flow | -294.22M |
Capital Expenditures | -1.95M |
Free Cash Flow | -296.17M |
FCF Per Share | -3.32 |
Margins
Gross Margin | 47.70% |
Operating Margin | -30,619.10% |
Pretax Margin | -29,246.40% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TPEX:6492 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -8.46% |
FCF Yield | -8.53% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:6492 has an Altman Z-Score of 63.73.
Altman Z-Score | 63.73 |
Piotroski F-Score | n/a |